Home › Hereditary Sensory and Autonomic Neuropathies › District of Columbia
Hereditary Sensory and Autonomic Neuropathies clinical trials in District of Columbia
3 studies for Hereditary Sensory and Autonomic Neuropathies are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- George Washington University Medical, Washington D.C.
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
- Johns Hopkins University, Washington D.C.
RecruitingObservational study
Ages 1 to 100 · All sexes · Updated Apr 1, 2026 · NCT05868629From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.